UltraSight raises $24 million in Series B2 financing to expand its AI-guided cardiac workflow platform across U.S. health systems, led by Alive HealthTech Growth Fund.
Amount Raised
$24 Million
Round Type
Series B
BostonBiotechnologyHealth CareArtificial IntelligenceMedicalMedical DeviceMachine LearningHealth DiagnosticsInvestors
Description
UltraSight has successfully raised $24 million in Series B2 funding to support the commercial expansion of its Echosystem platform in the United States. This financing aims to develop high-value workflows for critical care settings and facilitate strategic collaborations. The funding was led by Alive HealthTech Growth Fund with participation from several other investors, including existing partners. This capital will help UltraSight enhance its market presence and improve cardiac imaging workflows.
Quick answer
UltraSight raised $24 Million in a Series B round, dated September 23, 2026. Investors: Iron Nation, Connecticut Innovations, Star51 Capital, Mayo Clinic Ventures, Nyu, eHealth Ventures, Alive HealthTech Growth Fund and Deep Insight. UltraSight is based in Boston, Massachusetts, United States.
- How much did UltraSight raise?
- UltraSight raised $24 Million in a Series B round on September 23, 2026.
- Who invested in UltraSight?
- Iron Nation, Connecticut Innovations, Star51 Capital, Mayo Clinic Ventures, Nyu, eHealth Ventures, Alive HealthTech Growth Fund and Deep Insight are named as investors in this round.
- What does UltraSight do?
- UltraSight is a leader in AI-guided cardiac workflows, focused on enhancing cardiac care through its Echosystem platform.
- Where is UltraSight based and how big is it?
- UltraSight is based in Boston, Massachusetts, United States. Fundz records about 2 employees.
- Who are the decision-makers at UltraSight?
- Fundz holds 2 contacts at UltraSight, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as UltraSight that raised within 45 days of this round, from Fundz verified event records.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- AIBORN Ltd raised an undisclosed amount on October 5, 2026.
- Cascader raised an undisclosed amount (Seed) on September 23, 2026.
- Coherence Neuro raised $45M (Series A) on October 22, 2026.
- Scarlet raised $50M (Series B) on October 12, 2026.
- Positron raised $875M (Series C) on September 10, 2026.
Who to call at UltraSight, and when
A new round usually means UltraSight is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day UltraSight raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at UltraSight, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at UltraSight. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment UltraSight raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansUltraSight raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.